UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 77

Sortiert nach

Preoperative/neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of response and resection percentages

PLoS medicine, 2010-04, Vol.7 (4), p.e1000267-e1000267

2010

Link zum Volltext

Verfügbarkeit prüfen

Adenocarcinomas of the Esophagogastric Junction Are More Likely to Respond to Preoperative Chemotherapy than Distal Gastric Cancer

Annals of surgical oncology, 2012-07, Vol.19 (7), p.2108-2118

2012

Link zum Volltext

Verfügbarkeit prüfen

Early Response Assessment Using 3′-Deoxy-3′-[18F]Fluorothymidine-Positron Emission Tomography in High-Grade Non-Hodgkin's Lymphoma

Clinical cancer research, 2007-06, Vol.13 (12), p.3552-3558

2007

Link zum Volltext

Verfügbarkeit prüfen

The cytotoxicity of anti-CD22 immunotoxin is enhanced by bryostatin 1 in B-cell lymphomas through CD22 upregulation and PKC-βII depletion

Haematologica (Roma), 2012-05, Vol.97 (5), p.771-779

2012

Link zum Volltext

Verfügbarkeit prüfen

GM1 Expression of Non-Hodgkin's Lymphoma Determines Susceptibility to Rituximab Treatment

Cancer research (Chicago, Ill.), 2008-07, Vol.68 (13), p.5414-5422

2008

Link zum Volltext

Verfügbarkeit prüfen

Real-world multicentre analysis of neoadjuvant immunotherapy and chemotherapy in localized or oligometastatic non-small cell lung cancer (KOMPASSneoOP)

Therapeutic advances in medical oncology, 2022-03, Vol.14, p.17588359221085333-17588359221085333

2022

Link zum Volltext

Verfügbarkeit prüfen

Molecular Imaging of Proliferation and Glucose Utilization: Utility for Monitoring Response and Prognosis after Neoadjuvant Therapy in Locally Advanced Gastric Cancer

Annals of surgical oncology, 2011-11, Vol.18 (12), p.3316-3323

2011

Link zum Volltext

Verfügbarkeit prüfen

Imaging Proliferation to Monitor Early Response of Lymphoma to Cytotoxic Treatment

Molecular imaging and biology, 2008-11, Vol.10 (6), p.349-355

2008

Link zum Volltext

Verfügbarkeit prüfen

Imaging Bone and Soft Tissue Tumors with the Proliferation Marker [18F]Fluorodeoxythymidine

Clinical cancer research, 2008-05, Vol.14 (10), p.2970-2977

2008

Link zum Volltext

Verfügbarkeit prüfen

Antihuman epidermal growth factor receptor 2 (HER2) monoclonal antibody trastuzumab enhances cytolytic activity of class I-restricted HER2-specific T lymphocytes against HER2-overexpressing tumor cells

Cancer research (Chicago, Ill.), 2002-04, Vol.62 (8), p.2244-2247

2002

Link zum Volltext

Verfügbarkeit prüfen

MALT1 directs B cell receptor-induced canonical nuclear factor-κB signaling selectively to the c-Rel subunit

Nature immunology, 2007-09, Vol.8 (9), p.984-991

2007

Link zum Volltext

Verfügbarkeit prüfen

P1122: A PROSPECTIVE, NON‐INTERVENTIONAL STUDY OF REAL‐WORLD TREATMENT AND OUTCOME IN SECONDARY CNS LYMPHOMA

HemaSphere, 2023-08, Vol.7 (S3), p.e23520df-n/a

2023

Link zum Volltext

Verfügbarkeit prüfen

Significance of Histopathological Tumor Regression After Neoadjuvant Chemotherapy in Gastric Adenocarcinomas: A Summary of 480 Cases

Annals of surgery, 2011-05, Vol.253 (5), p.934-939

2011

Link zum Volltext

Verfügbarkeit prüfen

Multimodal treatment strategies for locally advanced rectal cancer

Expert review of anticancer therapy, 2012-04, Vol.12 (4), p.481-494

2012

Link zum Volltext

Verfügbarkeit prüfen

Osimertinib in Untreated EGFR-Mutated Advanced Non–Small-Cell Lung Cancer

The New England journal of medicine, 2018-01, Vol.378 (2), p.113-125

2018

Link zum Volltext

Verfügbarkeit prüfen

Proposal for a Multifactorial Prognostic Score That Accurately Classifies 3 Groups of Gastric Carcinoma Patients With Different Outcomes After Neoadjuvant Chemotherapy and Surgery

Annals of surgery, 2012-12, Vol.256 (6), p.1002-1007

2012

Link zum Volltext

Verfügbarkeit prüfen

18F-FDG PET and 18F-FDG PET/CT for Assessing Response to Therapy in Esophageal Cancer

The Journal of nuclear medicine (1978), 2009-05, Vol.50 (Suppl_1), p.89S-96S

2009

Link zum Volltext

Verfügbarkeit prüfen

T-cell lymphoproliferative disorder potentially induced by imatinib in a patient with GIST

Nature reviews. Clinical oncology, 2010-02, Vol.7 (2), p.116-119

2010

Link zum Volltext

Verfügbarkeit prüfen

(18)F-FDG PET-guided salvage neoadjuvant radiochemotherapy of adenocarcinoma of the esophagogastric junction: the MUNICON II trial

The Journal of nuclear medicine (1978), 2011-08, Vol.52 (8), p.1189-1196

2011

Link zum Volltext

Verfügbarkeit prüfen

The Generation of Both T Killer and Th Cell Clones Specific for the Tumor-Associated Antigen HER2 Using Retrovirally Transduced Dendritic Cells

The Journal of immunology (1950), 2001-08, Vol.167 (3), p.1712-1719

2001

Link zum Volltext

Verfügbarkeit prüfen

Assessing the efficacy and tolerability of PET-guided BrECADD versus eBEACOPP in advanced-stage, classical Hodgkin lymphoma (HD21): a randomised, multicentre, parallel, open-label, phase 3 trial

The Lancet (British edition), 2024-07

2024

Link zum Volltext

Verfügbarkeit prüfen

A prospective observational study of real-world treatment and outcome in secondary CNS lymphoma

European journal of cancer (1990), 2024-01, Vol.196, p.113436-113436, Article 113436

2024

Link zum Volltext

Verfügbarkeit prüfen

High-Dose Therapy (HDT) with Melphalan and Autologous Stem Cell Transplantation (ASCT) for Patients Older Than 70 Years with Multiple Myeloma

Blood, 2016-12, Vol.128 (22), p.3461-3461

2016

Link zum Volltext

Verfügbarkeit prüfen

Paclitaxel/carboplatin with or without belinostat as empiric first‐line treatment for patients with carcinoma of unknown primary site: A randomized, phase 2 trial

Cancer, 2015-05, Vol.121 (10), p.1654-1661

2015

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 77

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(76)
Mit Volltextzugriff
(73)

Publikationsform

Artikel
(76)
Buchkapitel
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Preoperative/neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of response and resection percentages

Adenocarcinomas of the Esophagogastric Junction Are More Likely to Respond to Preoperative Chemotherapy than Distal Gastric Cancer

Early Response Assessment Using 3′-Deoxy-3′-[18F]Fluorothymidine-Positron Emission Tomography in High-Grade Non-Hodgkin's Lymphoma

The cytotoxicity of anti-CD22 immunotoxin is enhanced by bryostatin 1 in B-cell lymphomas through CD22 upregulation and PKC-βII depletion

GM1 Expression of Non-Hodgkin's Lymphoma Determines Susceptibility to Rituximab Treatment

Real-world multicentre analysis of neoadjuvant immunotherapy and chemotherapy in localized or oligometastatic non-small cell lung cancer (KOMPASSneoOP)

Molecular Imaging of Proliferation and Glucose Utilization: Utility for Monitoring Response and Prognosis after Neoadjuvant Therapy in Locally Advanced Gastric Cancer

Imaging Proliferation to Monitor Early Response of Lymphoma to Cytotoxic Treatment

Imaging Bone and Soft Tissue Tumors with the Proliferation Marker [18F]Fluorodeoxythymidine

Antihuman epidermal growth factor receptor 2 (HER2) monoclonal antibody trastuzumab enhances cytolytic activity of class I-restricted HER2-specific T lymphocytes against HER2-overexpressing tumor cells

MALT1 directs B cell receptor-induced canonical nuclear factor-κB signaling selectively to the c-Rel subunit

P1122: A PROSPECTIVE, NON‐INTERVENTIONAL STUDY OF REAL‐WORLD TREATMENT AND OUTCOME IN SECONDARY CNS LYMPHOMA

Significance of Histopathological Tumor Regression After Neoadjuvant Chemotherapy in Gastric Adenocarcinomas: A Summary of 480 Cases

Multimodal treatment strategies for locally advanced rectal cancer

Osimertinib in Untreated EGFR-Mutated Advanced Non–Small-Cell Lung Cancer

Proposal for a Multifactorial Prognostic Score That Accurately Classifies 3 Groups of Gastric Carcinoma Patients With Different Outcomes After Neoadjuvant Chemotherapy and Surgery

18F-FDG PET and 18F-FDG PET/CT for Assessing Response to Therapy in Esophageal Cancer

T-cell lymphoproliferative disorder potentially induced by imatinib in a patient with GIST

(18)F-FDG PET-guided salvage neoadjuvant radiochemotherapy of adenocarcinoma of the esophagogastric junction: the MUNICON II trial

Sotorasib in KRAS G12C-mutated non-small cell lung cancer: A multicenter real-world experience from the compassionate use program in Germany

The Generation of Both T Killer and Th Cell Clones Specific for the Tumor-Associated Antigen HER2 Using Retrovirally Transduced Dendritic Cells

Assessing the efficacy and tolerability of PET-guided BrECADD versus eBEACOPP in advanced-stage, classical Hodgkin lymphoma (HD21): a randomised, multicentre, parallel, open-label, phase 3 trial

A prospective observational study of real-world treatment and outcome in secondary CNS lymphoma

High-Dose Therapy (HDT) with Melphalan and Autologous Stem Cell Transplantation (ASCT) for Patients Older Than 70 Years with Multiple Myeloma

Paclitaxel/carboplatin with or without belinostat as empiric first‐line treatment for patients with carcinoma of unknown primary site: A randomized, phase 2 trial

Suchergebnisse filtern